Publication Name	World Journal of Hepatology
Manuscript ID	27067
Country	Australia

Received	2016-05-08 12:38
Peer-Review Started	2016-05-10 11:54
To Make the First Decision	2016-06-06 11:05
Return for Revision	2016-07-18 16:23
Revised	2016-07-21 16:09
Second Decision	2016-09-12 09:52
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2016-09-22 14:42
Articles in Press	2016-09-22 14:42
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-12-26 09:15
Publish the Manuscript Online	2017-01-06 08:51

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Retrospective Study
Article Title	Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience
Manuscript Source	Unsolicited Manuscript
All Author List	Grace C Lovett, Tin Nguyen, David M Iser, Jacinta A Holmes, Robert Chen, Barbara Demediuk, Gideon Shaw, Sally J Bell, Paul V Desmond and Alexander J Thompson
Funding Agency and Grant Number
Corresponding Author	Alexander J Thompson, MBBS, FRACP, PhD, Department of Gastroenterology, St Vincent’s Hospital Melbourne, Level 4 Daly Wing, 35 Victoria Parade, Fitzroy 3065, Victoria, Australia. alexander.thompson@svha.org.au
Key Words	Tenofovir; Hepatitis B virus; Australia; Real-life; Virological suppression; Chronic hepatitis B
Core Tip	Clinical trials have demonstrated that teno-fovir is a safe and efficacious treatment for patients with chronic hepatitis B, with high rates of sustained virological suppression. There are limited data evaluating the safety and efficacy of tenofovir in real-world settings. The aim of this study was to evaluate the long-term treatment outcomes of tenofovir therapy in patients in an Australian tertiary care setting. We performed a retrospective analysis of treatment outcomes among treatment-na?ve and treatment-experienced patients.
Publish Date	2017-01-06 08:51
Citation	Lovett GC, Nguyen T, Iser DM, Holmes JA, Chen R, Demediuk B, Shaw G, Bell SJ, Desmond PV, Thompson AJ. Efficacy and safety of tenofovir in chronic hepatitis B: Australian real world experience. World J Hepatol 2017; 9(1): 48-56
URL	http://www.wjgnet.com/1948-5182/full/v9/i1/48.htm
DOI	http://dx.doi.org/10.4254/wjh.v9.i1.48

Full Article (PDF)	WJH-9-48.pdf
Full Article (Word)	WJH-9-48.doc
Manuscript File	27067-Review.docx
Answering Reviewers	27067-Answering reviewers.pdf
Audio Core Tip	27067-Audio core tip.mp3
Biostatistics Review Certificate	27067-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form	27067-Conflict-of-interest statement.pdf
Copyright License Agreement	27067-Copyright assignment.pdf
Signed Informed Consent Form(s) or Document(s)	Informed_Consent_Statement_20160507163232.pdf
Institutional Animal Care and Use Committee Approval Form or Document	Institutional_Animal_Care_and_Use_Committee_Statement_20160507164124.pdf
Institutional Review Board Approval Form or Document	27067-Institutional review board statement.pdf
Peer-review Report	27067-Peer-review(s).pdf
Scientific Misconduct Check	27067-Scientific misconduct check.pdf
Scientific Editor Work List	27067-Scientific editor work list.pdf